

[ Tue, Sep 24th 2024
] - WOPRAI

[ Tue, Aug 20th 2024
] - WOPRAI

[ Mon, Apr 01st 2024
] - WOPRAI

[ Tue, Jan 16th 2024
] - WOPRAI

[ Tue, Oct 31st 2023
] - WOPRAI


[ Tue, Sep 26th 2023
] - WOPRAI

[ Mon, Aug 14th 2023
] - WOPRAI

[ Fri, Aug 11th 2023
] - WOPRAI

[ Fri, May 19th 2023
] - WOPRAI

[ Thu, Jun 02nd 2022
] - WOPRAI

[ Thu, May 19th 2022
] - WOPRAI


[ Tue, Feb 08th 2022
] - WOPRAI


[ Thu, Jul 01st 2021
] - WOPRAI


[ Tue, Mar 30th 2021
] - WOPRAI

[ Thu, Mar 11th 2021
] - WOPRAI

[ Mon, Nov 30th 2020
] - WOPRAI
[ Mon, Nov 30th 2020
] - WOPRAI

[ Fri, Aug 21st 2020
] - WOPRAI
[ Fri, Aug 21st 2020
] - WOPRAI

[ Fri, Mar 27th 2020
] - WOPRAI

Joshua Dennerlein Maintained (AHR) at Strong Buy with Increased Target to $31 on, Sep 24th, 2024
Joshua Dennerlein of B of A Securities, Maintained "American Healthcare REIT, Inc." (AHR) at Strong Buy with Increased Target from $27 to $31 on, Sep 24th, 2024.
Joshua has made no other calls on AHR in the last 4 months.
There are 4 other peers that have a rating on AHR. Out of the 4 peers that are also analyzing AHR, 0 agree with Joshua's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joshua
- Aaron Hecht of "JMP Securities" Maintained at Buy with Increased Target to $30 on, Friday, September 20th, 2024
- Austin Wurschmidt of "Keybanc" Maintained at Buy with Increased Target to $28 on, Friday, September 20th, 2024
- Michael Lewis of "Truist Securities" Maintained at Strong Buy with Increased Target to $27 on, Friday, September 20th, 2024
- Ronald Kamdem of "Morgan Stanley" Maintained at Buy with Increased Target to $22 on, Thursday, August 22nd, 2024